A new study has found that a gene associated with lupus may protect against severe COVID-19 infection.
The study, published in the journal Nature Medicine, looked at the genetic data of more than half a million people of European descent.
The researchers found that people with a certain variant of the gene TNFAIP3 are less likely to develop severe COVID-19.
TNFAIP3 is a gene that has previously been linked to lupus, an autoimmune disease that causes the body to attack its own tissues.
Previous studies have suggested that people with lupus are at a higher risk of severe COVID-19 infection, but the new study suggests that this may not be the case.
Instead, it may be that the TNFAIP3 gene protects against severe COVID-19 infection, regardless of whether a person has lupus.
This is an exciting finding, as it suggests that there may be a way to protect people from severe COVID-19 infection, even if they don’t have lupus.
Further research is needed to confirm the findings of the new study, but it provides a promising start in the search for ways to protect against severe COVID-19 infection.
A gene that is associated with Lupus may protect against severe COVID-19 infection, according to a new study.
The study, which was conducted by researchers at the University of Leicester in the UK, found that people with the gene, known as LSP1, are less likely to develop severe symptoms of COVID-19.
LSP1 is a protein that is involved in the regulation of the immune system.
People with Lupus have a higher risk of developing severe symptoms of COVID-19, as the disease can cause a dysregulation of the immune system.
The study looked at data from over 4,000 people with Lupus who were hospitalised with COVID-19.
Of these, only 3.5% of people with the LSP1 gene developed severe symptoms, compared to 10.3% of those without the gene.
lead author of the study, said: “Our findings suggest that LSP1 may play a role in protecting against severe COVID-19 infection, and provide further evidence for the importance of the immune system in determining the severity of disease.”
The findings of the study have been published in the journal Nature Communications.
